Guatemala HIV AIDS Industry Outlook 2022 - 2026

See how Guatemala HIV AIDS performed compared to key markets such as South Africa, Nigeria and Mozambique.

Key Market Indicators

In Guatemala, HIV/AIDS prevalence among people aged 0-14 is projected to drop by 0.8% on average each year over the next five years. This is a decrease of 3.6% since 1995. In 2021, Guatemala was ranked 45th out of all countries in the world, with 2,740 persons aged 0-14 living with HIV/AIDS. Liberia was the highest-ranking country, followed by Nigeria, Mozambique and Tanzania. Treatment coverage for those living with HIV in Guatemala is expected to grow by 2.7 points annually over the next five years, increasing from 67% in 2021 to 79% in 2026. This is a 6.9 point increase since 2008. In 2021, Guatemala was ranked 70th out of all countries in the world, with 67% of people living with HIV receiving treatment. Serbia was top of the list, followed by Cape Verde, Latvia and Zimbabwe.

Guatemala HIV AIDS Market Data and Forecasts

How much will Guatemala HIV AIDS Market grow to 2026?

Forecast: Incidence of Tuberculosis (Including HIV-Positive Cases) in Guatemala
Forecast: Estimated AIDS Deaths in Guatemala

Other Top Countries about HIV AIDS